Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return.
New 3-D simulation models that include haemodynamics enable better treatment of hepatic tumours via radio-embolisation, according to eminent Spanish radiologist José Ignacio Bilbao Jaureguizar.
Fernando López Zárraga is a member of the Executive Board of the Spanish Society of Vascular and Interventional Radiology (SERVEI). In an interview with European Hospital he explains issues facing interventional radiology in Spain and why this is becoming an increasingly attractive field.
Prostate cancer patients may soon have a new option to treat their disease: laser heat. UCLA researchers have found that focal laser ablation – the precise application of heat via laser to a tumor – is both feasible and safe in men with intermediate risk prostate cancer.
Researchers have found that a combination of chemotherapy and modern radiotherapy can benefit patients with advanced nasopharyngeal cancer – a cancer that starts at the back of the nose. These cancers are very rare in the UK and so modern treatments had not been previously studied in patients with advanced disease.
On March 3, Radiotherapy Group clinicians at Ziekenhuis Gelderse Vallei (Ede, the Netherlands) used their Esteya electronic brachytherapy system for the first time to treat a 73-year-old male patient with a nodular basal cell carcinoma on his nose. Esteya is a form of high dose rate (HDR) brachytherapy that applies high-precision radiotherapy directly to the cancer site, minimizing radiation to…
Accuray Incorporated announced today that the first centers in Qatar, Latvia, and Bulgaria are now equipped with its radiation therapy technology, demonstrating continued momentum in adoption of its devices in Europe, India, the Middle East and Africa (EIMEA). The CyberKnife® and TomoTherapy® Systems are now used in more than 40 countries to treat patients across the full spectrum of radiation…
Dr Gerald Antoch, professor of radiology and chairman of the department of diagnostic and interventional radiology at Düsseldorf University Hospital and active member of several scientific societies, delivered the prestigious Wilhelm Conrad Röntgen Honorary Lecture at ECR 2015 on ‘Hybrid imaging: Let the two worlds of radiology and nuclear medicine come together’.
Report:…
Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later. These results presented Professor James Morris, from the Department of Radiation Oncology, Vancouver…
The O-arm has successfully established as a gold standard imaging device for high contrast items in the market. Surgeons, all over the world consider the O-arm their system of choice, convinced by image quality, ease of handling, and reliability.
Radiotherapy always encounters particular challenges when a tumour is ‘mobile’. This is when radiotherapy must be carried out over several weeks. Within that period the tumour position, shape and expansion typically will keep changing. Thus radiotherapy needs continuous adaptation to maintain continuously precise radiation.
Report: Chrissanthi Nikolakudi
Dr Alex Horton, Consultant Radiologist at the Royal Surrey County Hospital NHS Foundation Trust in the UK, discusses how the latest development in point-of-care ultrasound systems, SonoSite’s X-Porte™ Ultrasound Kiosk, combines good image quality and robustness in a way that is ideal for use in the interventional radiology suite.
Clinicians and companies remain committed to a procedure that failed to demonstrate efficacy against a sham-control group in pivotal clinical trial
Efforts to unify training and certification, a regulatory environment conducive to innovation and a growing bank of clinical evidence for key procedures, is helping interventional radiology (IR) to move to a new level.
There are five big names in ultrasound that sell three out of four systems. Then there is Esaote, the biggest name among hundreds of small companies competing for a place in what is by far the largest, and most innovative market for medical imaging.
It was long overdue: Seven years after the arrival of the USA’s Image Wisely and Image Gently Campaigns, a European campaign for greater radiation protection in diagnostic and interventional imaging has arrived.
Over the next few years, the University Medical Center (UMC) Utrecht and Quirem Medical will be working closely together to maximize the benefits of using holmium microspheres to treat liver cancer patients worldwide.
In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy – delivered directly through a tumor’s blood supply – is working.
‘No large incision, no scalpel and no sutures: Radiologically guided, minimally invasive procedures can help many patients with chronic pain when conservative procedures don’t work,’ said Professor Siegfried Thurnher, head of the Department of Radiology and Nuclear Medicine at Vienna’s Hospital of St. John of God.
Hybrid operating theatres that combine conventional surgical tools with image-guided diagnostic tools, allow cardiologists and cardiac surgeons to perform minimally invasive surgery (MIS).
Taking a comprehensive approach to reducing dose, each link in the imaging chain was reengineered to deliver a superior clinical image with Ziehm Vision mobile C-arms. The importance of imaging for interventional radiologists is clear the moment you step into the operating theatre.
The European market for interventional radiology and cardiology is heading towards maturity, especially in Western Europe. Although the economic slowdown and fewer orders had a negative impact on revenues in 2012, it is expected that expanding applications of interventional systems and the popularisation of hybrid solutions will drive market growth over the 2013-2017 period.
Dr. Paula Martínez Miravete didn’t set out to change breast imaging in Spain when she first adopted breast tomosynthesis.
In a Special Focus Session, experts addressed the necessity to perform palliative interventional techniques in cancer treatment and they insisted that interventional radiologists should become more than just technicians.
In the highly competitive US market for interventional radiology, Siemens introduced a ground-breaking new imaging chain for the Artis line that sets a new standard for image quality.
